TOP TIERMARKET NEWSWIRE

News & sentiment

INNATE PHARMA S A ADR (IPHA) — News & AI sentiment

INNATE PHARMA S A ADR (IPHA) news roundup. 2 stories in the past week, 4 over 30 days. Average 30-day sentiment is 53/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

2

avg sentiment 55/100

30d stories

4

avg sentiment 53/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

IPHA news in the last 24 hours, 7 days, 30 days and 90 days

How much IPHA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	IPHA stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	2	55/100	IPHA headlines →
Last 30 days	4	53/100	IPHA headlines →
Last 90 days	32	56.1/100	IPHA headlines →

Latest stories on IPHA

Innate Pharma announces AstraZeneca updated timing for PACIFIC-9 data readout

The Fly58 · neutralproduct/pr

5d ago

Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027

StockTitan52 · neutralproduct/pr

5d ago

Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference

StockTitan52 · neutralproduct/pr

Oct 21

Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update

StockTitan50 · neutralgeneral

Oct 20

Innate Pharma (IPHA) Closes Sobi Deal. Can the New Funding Keep Drug Trials on Track?

Yahoo Finance58 · neutralm&a

Sep 23

Innate Pharma S.A. 2026 Q2 - Results - Earnings Call Presentation

Seeking Alpha50 · neutralearnings

Sep 22

Innate Pharma stock maintained at Buy by H.C. Wainwright

Investing.com Analyst Ratings61 · neutralanalyst

Sep 21

Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript

Yahoo Top63 · neutralearnings

Sep 18

Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript

The Motley Fool63 · neutralearnings

Sep 18

Innate Pharma S.A. (IPHA) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Sep 17

Innate Pharma Q2 Earnings Call Highlights

Yahoo Top63 · neutralearnings

Sep 17

Innate Pharma gives H1 results

Seeking Alpha48 · neutralearnings

Sep 17

Innate Pharma Reports First Half 2026 Business Update and Financial Results

StockTitan38 · neutralgeneral

Sep 17

Sobi and Innate announce partnership is now effective following completion of closing conditions

PR Newswire66 · bullishproduct/pr

Sep 17

Innate Pharma says previously announced partnership with Sobi now effective

The Fly56 · neutralproduct/pr

Sep 16

Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions

StockTitan66 · bullishproduct/pr

Sep 16

Innate Pharma, Grove, and more set to report earnings Thursday

Investing.com Markets50 · neutralearnings

Sep 16

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

StockTitan50 · neutralgeneral

Sep 10

Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

StockTitan55 · neutralgeneral

Sep 2

Innate Pharma S.A. (IPHA) Discusses EUR 30 Million Equity Raise, Strategic Partnership and Pipeline Advancement Transcript

Seeking Alpha28 · bearishgeneral

Aug 14

Innate Pharma Announces Conference Call and Webcast

StockTitan50 · neutralgeneral

Aug 14

At a glance: stocks gapping up premarket

Seeking Alpha63 · neutralgeneral

Aug 11

Leerink Upgrades Innate Pharma To Outperform After Lacutamab Deal

The Fly61 · neutralanalyst

Aug 11

Innate Pharma Upgraded To Outperform From Market Perform At Leerink

The Fly61 · neutralanalyst

Aug 11

Innate Pharma Price Target Raised To 7 From 5 At H C Wainwright

The Fly63 · neutralanalyst

Aug 10

Open IPHA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →